Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-19-011017

Options or other derivatives

  • Chief Operating Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bazemore Todd · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-10-12 Grant or award : show line 1 in the form Stock Option (right to buy) +175,000 $3.45 2029-10-11 175,000 175,000 D
Loading xslF345X03/edgar.xml…